Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?

The HIV care cascade in Switzerland

(2015) Philipp Kohler et al.   AIDS

Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999–2011

(2015) Kate Buchacz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance

(2015) Lize Cuypers et al.   Viruses-Basel

HIV protease inhibitors in gut barrier dysfunction and liver injury

(2014) Xudong Wu et al.   CURRENT OPINION IN PHARMACOLOGY

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study

(2014) Fabia zu Knyphausen et al.   PLoS One

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany

(2014) Daniel Schmidt et al.   PLoS One

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

(2013) A. De Luca et al.   JOURNAL OF INFECTIOUS DISEASES

Frequent and Variable Cytotoxic-T-Lymphocyte Escape-Associated Fitness Costs in the Human Immunodeficiency Virus Type 1 Subtype B Gag Proteins

(2013) C. L. Boutwell et al.   JOURNAL OF VIROLOGY

Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection

(2012) Luigia Elzi et al.   ARCHIVES OF INTERNAL MEDICINE

HIV-1 p6 — a structured to flexible multifunctional membrane-interacting protein

(2012) Sara Marie Øie Solbak et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients

(2012) Alexandra U. Scherrer et al.   PLoS One

On the Role of the SP1 Domain in HIV-1 Particle Assembly: a Molecular Switch?

(2011) S. A. K. Datta et al.   JOURNAL OF VIROLOGY

Polymorphism in Gag Gene Cleavage Sites of HIV-1 Non-B Subtype and Virological Outcome of a First-Line Lopinavir/Ritonavir Single Drug Regimen

(2011) Jade Ghosn et al.   PLoS One

Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly

(2011) Jörg Votteler et al.   Retrovirology

Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity

(2010) Chris M. Parry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors

(2010) Y. Koh et al.   JOURNAL OF VIROLOGY

HIV-associated lipodystrophy: from fat injury to premature aging

(2010) Martine Caron-Debarle et al.   TRENDS IN MOLECULAR MEDICINE

Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance

(2009) Annemarie M.J. Wensing et al.   ANTIVIRAL RESEARCH

Long‐Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment–Experienced Patients in Switzerland

(2009) Viktor von Wyl et al.   CLINICAL INFECTIOUS DISEASES

Cohort Profile: The Swiss HIV Cohort Study

(2009) et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

(2009) Birgitte B. Simen et al.   JOURNAL OF INFECTIOUS DISEASES

Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1

(2009) C. M. Parry et al.   JOURNAL OF VIROLOGY

Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use

(2009) Thuy Le et al.   PLoS One

Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss

(2009) Elisabeth Dam et al.   PLoS Pathogens

Interplay of Reverse Transcriptase Inhibitor Therapy and Gag p6 Diversity in HIV Type 1 Subtype G and CRF02_AG

(2008) Akinyemi I. Ojesina et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Rtreemix: an R package for estimating evolutionary pathways and genetic progression scores

(2008) J. Bogojeska et al.   BIOINFORMATICS

Refined study of the interaction between HIV-1 p6 late domain and ALIX

(2008) Carine Lazert et al.   Retrovirology